This review focuses on the molecular mechanism of the cGAS-STING signaling pathway, analyzing its relationship to tumor immunity, and discussing how the innate immune pathway cGAS-STING transforms “cold” tumors into “hot” tumors, thereby further enhancing the therapeutic effect of ICIs. The gene discussed is STING1; the disease is neoplasm.